-
Alexopoulou L, Holt AC, Medzhitov R, Flavell RA, 2001: Recognition of double-stranded rna and activation of nf-kappab by toll-like receptor 3[J]. Nature, 413, 732-738. doi: 10.1038/35099560
-
Allred DC, Harvey JM, Berardo M, Clark GM, 1998: Prognostic and predictive factors in breast cancer by immunohistochemical analysis[J]. Mod Pathol, 11, 155-168.
-
Bauer J, Bien CG, Lassmann H, 2002: Rasmussen’s encephalitis: A role for autoimmune cytotoxic t lymphocytes[J]. Curr Opin Neurol, 15, 197-200. doi: 10.1097/00019052-200204000-00012
-
Bien CG, Bauer J, Deckwerth TL, Wiendl H, Deckert M, Wiestler OD, Schramm J, Elger CE, Lassmann H, 2002: Destruction of neurons by cytotoxic t cells: A new pathogenic mechanism in rasmussen’s encephalitis[J]. Ann Neurol, 51, 311-318. doi: 10.1002/(ISSN)1531-8249
-
Bien CG, Granata T, Antozzi C, Cross JH, Dulac O, Kurthen M, Lassmann H, Mantegazza R, Villemure JG, Spreafico R, Elger CE, 2005: Pathogenesis, diagnosis and treatment of rasmussen encephalitis: A european consensus statement[J]. Brain, 128, 454-471. doi: 10.1093/brain/awh415
-
Bsibsi M, Ravid R, Gveric D, van Noort JM, 2002: Broad expression of toll-like receptors in the human central nervous system[J]. J Neuropathol Exp Neurol, 61, 1013-1021. doi: 10.1093/jnen/61.11.1013
-
Chen S, Guan Y, Zhang Y, Qi X, An J, Wang Y, Luan G, 2016: Elevated expression of human papillomavirus antigen in brain tissue of patients with rasmussen’s encephalitis[J]. Epilepsy Res, 126, 119-125. doi: 10.1016/j.eplepsyres.2016.07.008
-
Eeg-Olofsson O, Bergström T, Andermann F, Andermann E, Olivier A, Rydenhag B, 2004: Herpesviral DNA in brain tissue from patients with temporal lobe epilepsy[J]. Acta Neurol Scand, 109, 169-174. doi: 10.1046/j.1600-0404.2003.00238.x
-
Farrell MA, Cheng L, Cornford ME, Grody WW, Vinters HV, 1991: Cytomegalovirus and rasmussen’s encephalitis[J]. Lancet, 337, 1551-1552.
-
Friedman H, Ch’ien L, Parham D, 1977: Virus in brain of child with hemiplegia, hemiconvulsions, and epilepsy[J]. Lancet, 2, 666-.
-
Guan Y, Zhou J, Luan G, Liu X, 2014: Surgical treatment of patients with rasmussen encephalitis[J]. Stereotact Funct Neurosurg, 92, 86-93. doi: 10.1159/000355901
-
Jay V, Becker LE, Otsubo H, Cortez M, Hwang P, Hoffman HJ, Zielenska M, 1995: Chronic encephalitis and epilepsy (rasmussen’s encephalitis): Detection of cytomegalovirus and herpes simplex virus 1 by the polymerase chain reaction and in situ hybridization[J]. Neurology, 45, 108-117. doi: 10.1212/WNL.45.1.108
-
Mantegazza R, Bernasconi P, Baggi F, Spreafico R, Ragona F, Antozzi C, Bernardi G, Granata T, 2002: Antibodies against glur3 peptides are not specific for rasmussen’s encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizures[J]. J Neuroimmunol, 131, 179-185. doi: 10.1016/S0165-5728(02)00261-8
-
Matin N, Tabatabaie O, Falsaperla R, Lubrano R, Pavone P, Mahmood F, Gullotta M, Serra A, Di Mauro P, Cocuzza S, Vitaliti G, 2015: Epilepsy and innate immune system: A possible immunogenic predisposition and related therapeutic implications[J]. Hum Vaccin Immunother, 11, 2021-2029. doi: 10.1080/21645515.2015.1034921
-
Pardo CA, Vining EP, Guo L, Skolasky RL, Carson BS, Freeman JM, 2004: The pathology of rasmussen syndrome: Stages of cortical involvement and neuropathological studies in 45 hemispherectomies[J]. Epilepsia, 45, 516-526. doi: 10.1111/epi.2004.45.issue-5
-
Power C, Poland SD, Blume WT, Girvin JP, Rice GP, 1990: Cytomegalovirus and rasmussen’s encephalitis[J]. Lancet, 336, 1282-1284. doi: 10.1016/0140-6736(90)92965-K
-
Rasmussen T, Olszewski J, Lloydsmith D, 1958: Focal seizures due to chronic localized encephalitis[J]. Neurology, 8, 435-445. doi: 10.1212/WNL.8.6.435
-
Rogers SW, Andrews PI, Gahring LC, Whisenand T, Cauley K, Crain B, Hughes TE, Heinemann SF, McNamara JO, 1994: Autoantibodies to glutamate receptor glur3 in rasmussen’s encephalitis[J]. Science, 265, 648-651. doi: 10.1126/science.8036512
-
Takahashi Y, Matsuda K, Kubota Y, Shimomura J, Yamasaki E, Kudo T, Fukushima K, Osaka H, Akasaka N, Imamura A, Yamada S, Kondo N, Fujiwara T, 2006: Vaccination and infection as causative factors in japanese patients with rasmussen syndrome: Molecular mimicry and hla class i[J]. Clin Dev Immunol, 13, 381-387. doi: 10.1080/17402520600589522
-
Varadkar S, Bien CG, Kruse CA, Jensen FE, Bauer J, Pardo CA, Vincent A, Mathern GW, Cross JH, 2014: Rasmussen’s encephalitis: Clinical features, pathobiology, and treatment advances[J]. Lancet Neurol, 13, 195-205. doi: 10.1016/S1474-4422(13)70260-6
-
Verma R, Bharti K, 2017: Toll like receptor 3 and viral infections of nervous system[J]. J Neurol Sci, 372, 40-48. doi: 10.1016/j.jns.2016.11.034
-
Walter GF, Renella RR, 1989: Epstein-barr virus in brain and rasmussen’s encephalitis[J]. Lancet, 1, 279-280.
-
Wang L, Wei D, Huang S, Peng Z, Le X, Wu TT, Yao J, Ajani J, Xie K, 2003: Transcription factor sp1 expression is a significant predictor of survival in human gastric cancer[J]. Clin Cancer Res, 9, 6371-6380.
-
Wiendl H, Bien CG, Bernasconi P, Fleckenstein B, Elger CE, Dichgans J, Mantegazza R, Melms A, 2001: Glur3 antibodies: Prevalence in focal epilepsy but no specificity for rasmussen’s encephalitis[J]. Neurology, 57, 1511-1514. doi: 10.1212/WNL.57.8.1511
-
Zhang Y, Wang Y, Chen S, Guan Y, Liu C, Li T, Luan G, An J, 2017: Expression of human cytomegalovirus components in the brain tissues of patients with rasmussen’s encephalitis[J]. Virol Sin, 32, 115-121. doi: 10.1007/s12250-016-3917-z